Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 18470700)

Published in Apoptosis on July 01, 2008

Authors

Kathrin Wennicke1, Françoise Debierre-Grockiego, Dominic Wichmann, Norbert W Brattig, Sabine Pankuweit, Bernhard Maisch, Ralph T Schwarz, Volker Ruppert

Author Affiliations

1: Department of Internal Medicine - Cardiology, Philipps-University of Marburg, University Hospital, Baldingerstrasse 1, 35043 Marburg/Lahn, Germany.

Articles by these authors

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34

A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50

The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science (2002) 2.98

Athlete's heart or hypertrophic cardiomyopathy? Clin Res Cardiol (2008) 2.32

Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol (2012) 2.28

Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem (2004) 2.23

Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2005) 2.11

Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol (2012) 2.05

Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol (2007) 1.95

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73

Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70

A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67

Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2011) 1.63

Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2010) 1.58

Method for aortic wall strain measurement with three-dimensional ultrasound speckle tracking and fitted finite element analysis. Ann Thorac Surg (2013) 1.56

Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology. Am Heart J (2006) 1.55

Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol (2002) 1.53

Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti. Nucleic Acids Res (2012) 1.49

Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation (2003) 1.47

Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab (2003) 1.46

Co-infection with two Chlamydophila species in a case of fulminant myocarditis. Crit Care Med (2007) 1.43

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J (2015) 1.42

Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology (2007) 1.42

Non-compaction cardiomyopathy in an adult with hereditary spherocytosis. Eur J Heart Fail (2006) 1.41

The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase. J Biol Chem (2006) 1.39

2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39

Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J (2006) 1.38

A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. Acta Trop (2010) 1.38

Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37

Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab (2004) 1.35

Endosymbiont DNA in endobacteria-free filarial nematodes indicates ancient horizontal genetic transfer. PLoS One (2010) 1.33

Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J (2013) 1.26

Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J (2012) 1.25

Inflammatory dilated cardiomyopathy (DCMI). Herz (2005) 1.21

Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J (2009) 1.19

Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis (2010) 1.16

Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin. J Crit Care (2011) 1.15

Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol (2008) 1.12

Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz (2006) 1.11

Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of tumor necrosis factor-alpha production in macrophages. J Biol Chem (2003) 1.11

Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs (2005) 1.10

Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest (2005) 1.09

IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS One (2009) 1.09

Identification of the archaeal alg7 gene homolog (encoding N-acetylglucosamine-1-phosphate transferase) of the N-linked glycosylation system by cross-domain complementation in Saccharomyces cerevisiae. J Bacteriol (2008) 1.09

Invasive pulmonary aspergillosis in the ICU: an emerging disease? Intensive Care Med (2013) 1.06

Onchocerca volvulus: expression and immunolocalization of a nematode cathepsin D-like lysosomal aspartic protease. Exp Parasitol (2004) 1.05

Molecular cloning of an alpha-enolase from the human filarial parasite Onchocerca volvulus that binds human plasminogen. Biochim Biophys Acta (2003) 1.04

Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab (2004) 1.02

High levels of circulating cardiac proteins indicate cardiac impairment in African children with severe Plasmodium falciparum malaria. Microbes Infect (2005) 1.02

Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. Europace (2006) 1.01

Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol (2003) 0.99

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol (2011) 0.98

Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol (2002) 0.98

Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol (2006) 0.97

Management strategies in pericardial emergencies. Herz (2006) 0.96

Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation. Am Heart J (2013) 0.96

Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function. Biochem Biophys Res Commun (2005) 0.96

Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging. Herz (2005) 0.95

Recognition of plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol Res (2002) 0.95

A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab (2008) 0.95

Human viral cardiomyopathy. Front Biosci (2003) 0.95

Virtual autopsy with multiphase postmortem computed tomographic angiography versus traditional medical autopsy to investigate unexpected deaths of hospitalized patients: a cohort study. Ann Intern Med (2014) 0.95

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz (2002) 0.94

Life cycle stage-resolved proteomic analysis of the excretome/secretome from Strongyloides ratti--identification of stage-specific proteases. Mol Cell Proteomics (2011) 0.94

The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda). Microbes Infect (2002) 0.94

Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev (2013) 0.93

Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol (2012) 0.93

The immunogenic properties of protozoan glycosylphosphatidylinositols in the mosquito Anopheles gambiae. Dev Comp Immunol (2008) 0.93

Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis. Vaccine (2011) 0.93

Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation (2004) 0.93

Inhibitors of glycosyl-phosphatidylinositol anchor biosynthesis. Biochimie (2003) 0.92

Synthesis of chloroplast galactolipids in apicomplexan parasites. Eukaryot Cell (2002) 0.92

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92

Genes for glycosylphosphatidylinositol toxin biosynthesis in Plasmodium falciparum. Infect Immun (2002) 0.91

The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target. Mol Biochem Parasitol (2009) 0.91

Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria. Arterioscler Thromb Vasc Biol (2011) 0.91